NAFDAC Alerts Nigerians to Fake Diabetes Drug in Circulation

NAFDAC has issued a public alert regarding counterfeit versions of the diabetes medication Forxiga circulating in Nigeria. The agency warns that these fake drugs, which mimic the brand's identity, pose significant health risks including treatment failure and harmful side effects.
Why it matters
Counterfeit pharmaceuticals are a major public health threat in developing regions, potentially leading to severe medical complications or death for patients relying on life-saving medication.
By Saheed Oyelakin Kindly share this story:
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in